1,513 results on '"Rivero, Antonio"'
Search Results
152. Darunavir en la coinfección por VIH/VHB y/o VHC
153. Indirect effects of cytomegalovirus infection in solid organ transplant recipients
154. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients
155. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
156. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients
157. A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers
158. Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection
159. A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure
160. Detection of Hepatitis E Virus in Hyalomma lusitanicum Ticks Feeding on Wild Boars
161. Una introducción a la salud en las escuelas en tiempos de COVID-19
162. La huella de la Real Academia Española en manuales de enseñanza de la lengua para la Educación Secundaria: el caso de la oración
163. CD46 Genetic Variability and HIV-1 Infection Susceptibility
164. Limited value of single sampling for IgM antibody determination as a diagnostic approach for acute hepatitis E virus infection
165. Learning in neural mass model networks
166. Modelling of egocentric space and allocentric space from neural activity in behaving mice
167. Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection
168. Inferring the connectivity of coupled chaotic oscillators using Kalman filtering
169. Detection of Hepatitis E virus in Hyalomma lusitanicum ticks feeding on wild boars
170. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
171. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis
172. Ensayo clínico aleatorizado para evaluar tres pautas cortas de tratamiento de la infección latente tuberculosa en pacientes infectados por el VIH
173. Recomendaciones españolas sobre el uso adecuado de enfuvirtida
174. Risk Factors for PulmonaryAspergillus terreusInfection in Patients With Positive Culture for Filamentous Fungi
175. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain
176. HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma
177. Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-doze zidovudine and lamivudine, as initial therapy for patients infected with HIV
178. Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection
179. The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients
180. The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype
181. A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
182. Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
183. Diarrhoea‐causing enteric protist species in intensively and extensively raised pigs (Sus scrofa domesticus) in Southern Spain. Part II: Association with Hepatitis E virus susceptibility.
184. Diarrhoea‐causing enteric protist species in intensively and extensively raised pigs (Sus scrofa domesticus) in Southern Spain. Part I: Prevalence and genetic diversity.
185. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus–coinfected patients
186. The impact of IL28B rs12979860 SNP and advanced liver fibrosis on response-guided therapy in HIV/HCV coinfected patients of particular clinical interest: 943
187. Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
188. Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis
189. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
190. LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients
191. Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
192. Development and Clinical Validation of a Pangenotypic PCR-Based Assay for the Detection and Quantification of Hepatitis E Virus ( Orthohepevirus A Genus)
193. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
194. Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/00 study
195. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients
196. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy
197. Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients
198. Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients
199. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients
200. Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.